Drug Profile
MM 401
Alternative Names: MM-401Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator University of Michigan
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA methylation modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Leukaemia
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Leukaemia in USA (unspecified route) (Ascentage Pharma pipeline, August 2023)
- 28 Apr 2020 No recent reports of development identified for preclinical development in Leukaemia in USA
- 17 Mar 2016 Preclinical trials in Leukaemia in USA (unspecified route)